Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	ADGRV1 DYSF FAT1 FAT2 PCDH15 NID1 C1S PLCG1 UNC13B FAT4 PCDHGB1 CALR FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 GUCA1B LRP2 PLCH1 ATP2A1 PCDH1 CDH6	3.17e-06	749	221	24	GO:0005509
GeneOntologyMolecularFunction	calcium-dependent phospholipase C activity	PLCG1 PLCH1	1.22e-04	2	221	2	GO:0050429
GeneOntologyMolecularFunction	phosphatidylinositol trisphosphate phosphatase activity	TPTE TPTE2 INPP5J	2.07e-04	11	221	3	GO:0034594
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	1.02e-07	187	218	13	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	3.07e-05	313	218	13	GO:0098742
GeneOntologyBiologicalProcess	alcohol metabolic process	MOXD2P LRAT DYSF ALG5 PLCG1 ALDH2 ALDH1B1 FMO5 THTPA ALG11 LEPR BCO1 ABCA5 LRP2 INPP5J	3.50e-05	412	218	15	GO:0006066
Domain	CA	FREM2 FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	7.68e-11	115	219	14	SM00112
Domain	Cadherin	FREM2 FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	1.09e-10	118	219	14	IPR002126
Domain	Cadherin_CS	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	4.81e-10	109	219	13	IPR020894
Domain	CADHERIN_1	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	7.58e-10	113	219	13	PS00232
Domain	Cadherin	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	7.58e-10	113	219	13	PF00028
Domain	CADHERIN_2	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	8.47e-10	114	219	13	PS50268
Domain	-	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	8.47e-10	114	219	13	2.60.40.60
Domain	Cadherin-like	FAT1 FAT2 PCDH15 FAT4 PCDHGB1 FAT3 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1 CDH6	1.05e-09	116	219	13	IPR015919
Domain	-	ADGRV1 FAT1 FAT2 FAT4 COL12A1 CALR FAT3 CELSR2	1.59e-05	95	219	8	2.60.120.200
Domain	C2_dom	TPTE DYSF WWC2 PLCG1 WWC1 UNC13B TPTE2 PLCH1 SNRNP200 PLCE1	2.44e-05	164	219	10	IPR000008
Domain	Laminin_G	FAT1 FAT2 FAT4 COL12A1 FAT3 CELSR2	5.91e-05	58	219	6	IPR001791
Domain	TPR-contain_dom	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD5 RGPD8 TTC17 EDRF1	7.07e-05	150	219	9	IPR013026
Domain	LAM_G_DOMAIN	FAT1 FAT2 FAT4 FAT3 CELSR2	7.76e-05	38	219	5	PS50025
Domain	Calx_beta	ADGRV1 FREM2 FRAS1	8.53e-05	8	219	3	SM00237
Domain	TPR_1	NASP SRP72 GTF3C3 PEX5 RGPD5 RGPD8 TTC17	9.07e-05	90	219	7	IPR001440
Domain	TPR_1	NASP SRP72 GTF3C3 PEX5 RGPD5 RGPD8 TTC17	9.07e-05	90	219	7	PF00515
Domain	EGF_CA	FAT1 FAT2 NID1 C1S FAT4 FAT3 CELSR2 LRP2	9.63e-05	122	219	8	SM00179
Domain	Laminin_G_2	FAT1 FAT2 FAT4 FAT3 CELSR2	9.97e-05	40	219	5	PF02210
Domain	EGF-like_Ca-bd_dom	FAT1 FAT2 NID1 C1S FAT4 FAT3 CELSR2 LRP2	1.08e-04	124	219	8	IPR001881
Domain	Cadherin_2	PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 PCDH1	1.13e-04	65	219	6	PF08266
Domain	Cadherin_N	PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 PCDH1	1.13e-04	65	219	6	IPR013164
Domain	Calx_beta	ADGRV1 FREM2 FRAS1	1.27e-04	9	219	3	IPR003644
Domain	Calx-beta	ADGRV1 FREM2 FRAS1	1.27e-04	9	219	3	PF03160
Domain	TPR_REGION	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD5 RGPD8 TTC17 EDRF1	1.47e-04	165	219	9	PS50293
Domain	TPR	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD5 RGPD8 TTC17 EDRF1	1.47e-04	165	219	9	PS50005
Domain	LamG	FAT1 FAT2 FAT4 FAT3 CELSR2	1.58e-04	44	219	5	SM00282
Domain	ASX_HYDROXYL	FAT1 NID1 C1S FAT4 FAT3 CELSR2 LRP2	1.76e-04	100	219	7	PS00010
Domain	IG_FLMN	FLNB FLNC TRIM45	1.80e-04	10	219	3	SM00557
Domain	Filamin	FLNB FLNC TRIM45	2.45e-04	11	219	3	PF00630
Domain	FILAMIN_REPEAT	FLNB FLNC TRIM45	2.45e-04	11	219	3	PS50194
Domain	Filamin/ABP280_rpt	FLNB FLNC TRIM45	2.45e-04	11	219	3	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNB FLNC TRIM45	2.45e-04	11	219	3	IPR017868
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT1 NID1 C1S FAT4 FAT3 CELSR2 LRP2	2.53e-04	106	219	7	IPR000152
Domain	-	HLA-DRB1 HLA-E NOMO2 NTM CRLF3 KIT FLNB COL6A3 FLNC FLT3 COL12A1 SEMA7A OBSL1 LEPR OPCML TRIM45 NOMO3 SEMA3E EPHA7	3.16e-04	663	219	19	2.60.40.10
Domain	-	DYSF WWC2 PLCG1 WWC1 UNC13B PLCH1 SNRNP200 PLCE1	3.64e-04	148	219	8	2.60.40.150
Domain	Growth_fac_rcpt_	GPR179 FAT1 NID1 FAT4 FRAS1 CELSR2 LRP2 EPHA7	5.17e-04	156	219	8	IPR009030
Domain	EGF_CA	FAT1 NID1 C1S FAT4 FAT3 LRP2	5.23e-04	86	219	6	PF07645
Domain	EF-hand_like	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	PF09279
Domain	PI-PLC-Y	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	PF00387
Domain	PLCYc	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	PS50008
Domain	PI-PLC_fam	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	IPR001192
Domain	PLC_EF-hand-like	PLCG1 PLCH1 PLCE1	6.52e-04	15	219	3	IPR015359
Domain	Ig-like_fold	HLA-DRB1 HLA-E NOMO2 NTM CRLF3 KIT FLNB COL6A3 FLNC FLT3 COL12A1 SEMA7A OBSL1 LEPR OPCML TRIM45 NOMO3 SEMA3E EPHA7	6.80e-04	706	219	19	IPR013783
Domain	ATP-gua_PtransN	CKB CKM	8.09e-04	4	219	2	PF02807
Domain	DUF2012	NOMO2 NOMO3	8.09e-04	4	219	2	PF09430
Domain	PHOSPHAGEN_KINASE	CKB CKM	8.09e-04	4	219	2	PS00112
Domain	ATP-gua_Ptrans	CKB CKM	8.09e-04	4	219	2	PF00217
Domain	-	CKB CKM	8.09e-04	4	219	2	1.10.135.10
Domain	ATP-guanido_PTrfase_N	CKB CKM	8.09e-04	4	219	2	IPR022413
Domain	ATP-guanido_PTrfase_AS	CKB CKM	8.09e-04	4	219	2	IPR022415
Domain	ATP-guanido_PTrfase_cat	CKB CKM	8.09e-04	4	219	2	IPR022414
Domain	DUF2012	NOMO2 NOMO3	8.09e-04	4	219	2	IPR019008
Domain	PHOSPHAGEN_KINASE_N	CKB CKM	8.09e-04	4	219	2	PS51509
Domain	PHOSPHAGEN_KINASE_C	CKB CKM	8.09e-04	4	219	2	PS51510
Domain	TPR	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD8 TTC17	8.26e-04	129	219	7	SM00028
Domain	EGF_Ca-bd_CS	FAT1 NID1 C1S FAT4 FAT3 LRP2	9.88e-04	97	219	6	IPR018097
Domain	TPR_repeat	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD8 TTC17	9.89e-04	133	219	7	IPR019734
Domain	EGF_CA	FAT1 NID1 C1S FAT4 FAT3 LRP2	1.10e-03	99	219	6	PS01187
Domain	PI-PLC-X	PLCG1 PLCH1 PLCE1	1.14e-03	18	219	3	PF00388
Domain	PLCXc	PLCG1 PLCH1 PLCE1	1.14e-03	18	219	3	SM00148
Domain	ConA-like_dom	TMPRSS15 ADGRV1 FAT1 FAT2 FAT4 COL12A1 CALR FAT3 CELSR2	1.15e-03	219	219	9	IPR013320
Domain	ATP-guanido_PTrfase	CKB CKM	1.34e-03	5	219	2	IPR000749
Domain	PIPLC_X_DOMAIN	PLCG1 PLCH1 PLCE1	1.34e-03	19	219	3	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCG1 PLCH1 PLCE1	1.34e-03	19	219	3	IPR000909
Domain	C2	DYSF WWC2 PLCG1 WWC1 UNC13B PLCH1 PLCE1	1.45e-03	142	219	7	PS50004
Domain	TPR-like_helical_dom	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD5 RGPD8 TTC17 EDRF1	1.77e-03	233	219	9	IPR011990
Domain	EGF	GPR179 FAT1 FAT2 NID1 FAT4 FRAS1 FAT3 CELSR2 LRP2	1.87e-03	235	219	9	SM00181
Domain	Gln_synth/guanido_kin_cat_dom	CKB CKM	1.99e-03	6	219	2	IPR014746
Domain	Tyr_kinase_CSF1/PDGF_rcpt	KIT FLT3	1.99e-03	6	219	2	IPR016243
Domain	-	CKB CKM	1.99e-03	6	219	2	3.30.590.10
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 DCAF6 PCGF2 WAPL HLA-DRB1 NASP TUBGCP5 ZEB2 BFSP1 PTPRA MIA2 NOMO2 USP7 C1S DLG2 PLCG1 TAF1 DYNC1I1 DNMT1 UNC13B NRBP1 FLNB ANK2 SYNM OBSL1 JAKMIP3 THOP1 SF3B1 NETO1 RCBTB1 NEMF RNF38 LRP2 TTC17 KDM4A SNRNP200	1.01e-13	1285	223	36	35914814
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	TPTE PSMB1 NAP1L4 CKB FANCD2 WWC2 PTPRA AGL NID1 PLCG1 NUP160 WWC1 NRBP1 FLNB FLNC CALR TPTE2 SMC4 OBSL1 ELP1 IPO4 THOP1 ARAP3 TTC17 UBE3C ATP2A1 SNRNP200	2.05e-10	974	223	27	28675297
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DCAF6 HLA-E SRP72 MDM2 DYSF AGL TAF1 FLNB COL6A3 FLNC AMPD1 COL12A1 ANK2 DOCK9 ELP1 DNAJA3 AKAP9 ATP2A1 PLCE1	6.65e-10	497	223	19	23414517
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PPP1R12A MIA2 PLCG1 FLNB FLNC ANK2 SEMA7A PCDHA8 PCDHA6 TDRD1 SUV39H2 LEPR CELSR2 LRP2	3.36e-08	329	223	14	17474147
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1	3.62e-08	77	223	8	10835267
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	PPP1R12A FAT2 USP7 FLNB RGPD8 FAT3 TEX15 YY1 LEPR SF3B1 PLCH1 SNRNP200	4.35e-08	234	223	12	36243803
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2 PCDH1	4.91e-08	80	223	8	10716726
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT1 FAT2 FAT4 FAT3	5.67e-08	7	223	4	16059920
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	DCAF6 PPP1R12A PSMB1 PEPD NAP1L4 NASP SRP72 CKB FANCD2 NSFL1C AGL USP7 PEX5 GMDS PLCG1 ALDH1B1 NUP160 ASF1A NRBP1 FLNB FLNC CALR SMC4 ELP1 IPO4 THOP1 PRMT3 UBE3C SNRNP200	6.83e-08	1455	223	29	22863883
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	WAPL PSMB1 SPATA18 PEPD NASP SRP72 GTF3C3 CKB FANCD2 USP7 KIF14 PLCG1 ALDH2 ALDH1B1 NUP160 ASF1A DNMT1 FLNB CALR SMC4 ELP1 IPO4 DNAJA3 SF3B1 NEMF PRMT3 UBE3C SNRNP200	1.57e-07	1425	223	28	30948266
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT1 FAT2 FAT3	2.60e-07	3	223	3	15744052
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 CELSR2	4.19e-07	72	223	7	10380929
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH6 PPP1R12A SRP72 GOLGA6A ZEB2 MIA2 DLG2 ATP11C ALDH2 ALDH1B1 DYNC1I1 RGPD5 RAD51B FLNB FLNC ANK2 RGPD8 PCDHGB1 GOLGA6D SMC4 YY1 SF3B1 SH3PXD2A AVIL PLCH1 ATP2A1 DOP1A	6.79e-07	1442	223	27	35575683
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	WAPL PPP1R12A MDM2 ZEB2 GTF3C3 BRD8 AGL KIT NUP160 NEMP1 FLNC NRF1 SMC4 OBSL1 AGGF1 YY1 TFDP1 SF3B1 RCBTB1 SNRNP200	7.93e-07	857	223	20	25609649
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	PSMB1 GTF3C3 FANCD2 ALDH1B1 SMC4 ELP1 IPO4 DNAJA3 UBE3C SNRNP200	1.21e-06	211	223	10	17314511
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	KIT FLT3 SEMA7A FAT3 NETO1 PCDH1 CDH6	2.08e-06	91	223	7	28558017
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZMYND11 WAPL RNF168 NASP ZEB2 GTF3C3 USP7 TAF1 ASF1A DNMT1 CALR YY1 SUV39H2 KIF20B TFDP1 KDM4A	2.30e-06	608	223	16	36089195
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	NASP AGL USP7 COL6A3 SMC4 ELP1 IPO4 THOP1 SF3B1	2.57e-06	179	223	9	36261009
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM2 NID1 FRAS1	2.58e-06	5	223	3	17596926
Pubmed	Bone Morphogenic Protein 4 Mediates NOX1-Dependent eNOS Uncoupling, Endothelial Dysfunction, and COX2 Induction in Type 2 Diabetes Mellitus.	NOS3 LEPR NOX1	2.58e-06	5	223	3	26121233
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NAP1L4 GTF3C3 C5orf34 NSFL1C NOMO2 GMDS ALDH2 DNMT1 NRBP1 FRAS1 ANK2 SYNM CALR OBSL1 ELP1 IPO4 TFDP1 DNAJA3 SF3B1 AKAP9 MRPL15 TTC17 PLCH1 SNRNP200 EDRF1 EPHA7	3.86e-06	1487	223	26	33957083
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	MDM2 DYSF COL6A3 COL12A1 FMO5 DOCK9 SMC4 LEPR THOP1 LRATD2 CDH6 EPHA7	4.55e-06	363	223	12	14691545
Pubmed	Integrin αIIb (CD41) plays a role in the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta.	ITGA2B ITGAV KIT	5.13e-06	6	223	3	23789102
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAPGEF6 WAPL SRP72 FREM2 GAPDHS DNMT1 FRAS1 OBSL1 ELP1 ARAP3 NEMF AACS PLCH1 HPS5 SEMA3E PLCE1	5.36e-06	650	223	16	38777146
Pubmed	Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.	DCAF6 CKB CKM FLNB FLNC	6.43e-06	41	223	5	18157088
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 PCDH1	8.37e-06	74	223	6	10817752
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT1 FAT4 FAT3	8.93e-06	7	223	3	22510986
Pubmed	BCAS2 regulates oocyte meiotic prophase I by participating in mRNA alternative splicing.	GOLGA6A FANCD2 KIT GOLGA6D TEX15	9.18e-06	44	223	5	38085152
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	ZNF562 RIPK1 MAP1A PSMB1 PTGR2 TUBGCP5 ZEB2 CKB FAT1 ALG5 TAF1 GAPDHS DYNC1I1 UNC13B COL12A1 NRF1 ELP1 THTPA ALG11 USP46 ZNF561 KDM4A MPND	1.10e-05	1293	223	23	15342556
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	NAP1L4 NASP FANCD2 RGPD5 FLNB FLNC RGPD8 SF3B1 SNRNP200	1.14e-05	215	223	9	35973513
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZMYND11 DCAF6 WAPL MAP1A PPP1R12A MDM2 TUBGCP5 FANCD2 FAT1 BRD8 USP7 PEX5 TAF1 WWC1 FAT3 OBSL1 PRDM5 YY1 TFDP1 DNAJA3 LRP2	1.18e-05	1116	223	21	31753913
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF6 PPP1R12A PEPD ARHGEF38 ADGRV1 PCYOX1L PLCG1 RAD51B FLNB NRF1 PCDHGB1 PORCN ARHGEF18 VTI1A ZHX2 PARP10 THOP1 NETO1 SH3PXD2A NEMF TTC17 UBE3C HPS5 PCDH1 DOP1A	1.20e-05	1489	223	25	28611215
Pubmed	Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.	ITGA2B ALDH2 ALDH1B1 KIT	1.32e-05	23	223	4	18971422
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPGEF6 WAPL PPP1R12A NAP1L4 NASP GTF3C3 BRD8 USP7 KIF14 TAF1 DNMT1 RGPD5 SMC4 SNRNP200	1.42e-05	549	223	14	38280479
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	NID1 COL6A3 FRAS1	1.42e-05	8	223	3	12766770
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	ITGA2B CKB NOMO2 USP7 PLCG1 FLNB FLNC SMC4 SF3B1 SNRNP200 NOMO3	1.55e-05	344	223	11	30333137
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	NASP CKB DLG2 DYNC1I1 DNMT1 UNC13B FLNB FLNC ELP1 IPO4 TFDP1 PRMT3	1.58e-05	411	223	12	36652389
Pubmed	A protein interaction framework for human mRNA degradation.	WAPL MAP1A PSMB1 GTF3C3 NOMO2 ALDH1B1 NUP160 CALR LEPR THOP1 NOMO3	1.68e-05	347	223	11	15231747
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 RAPGEF6 ZEB2 GTF3C3 KIF14 TAF1 FLNB RGPD8 GTF3C6 KIF20B TFDP1 LRP2	1.86e-05	418	223	12	34709266
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	NASP CKB USP7 MAP3K15 COL6A3 FLNC SMC4 KIF20B SNRNP200	2.01e-05	231	223	9	36597993
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	DCAF6 PSMB1 NASP SRP72 ADGRV1 CKB BRD8 AGL CLTB FLNB CALR ELP1 SNRNP200	2.13e-05	495	223	13	28581483
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	PSMB1 HLA-E NAP1L4 NASP GTF3C3 FOXRED2 NOMO2 AGL USP7 GMDS ALDH1B1 NUP160 RGPD5 RGPD8 SMC4 ELP1 IPO4 DNAJA3 SF3B1 UBE3C SNRNP200 NOMO3	2.21e-05	1257	223	22	37317656
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	NAGLU HLA-E ITGAV FAT1 NOMO2 ALG5 NID1 ALDH2 FLNB FLNC SEMA7A CALR ELP1 USP46 YY1 DNAJA3 PARP10 THOP1 AKAP9 CELSR2 VWA5A AKR7A3 SNRNP200 NOMO3	2.30e-05	1451	223	24	30550785
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SRP72 GTF3C3 CKB USP7 KIF14 NUP160 DNMT1 FLNB FLNC CALR SMC4 ELP1 IPO4 SF3B1 SNRNP200	2.37e-05	653	223	15	22586326
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	FREM2 COL6A3 FRAS1	3.02e-05	10	223	3	15345741
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	RIPK1 NAGLU SRP72 FANCD2 FOXRED2 NSFL1C ALG5 USP7 DNMT1 CALR THTPA ALG11 AKAP9 MRPL15 RCBTB1 UBE3C	3.29e-05	754	223	16	33060197
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6	3.31e-05	57	223	5	32633719
Pubmed	WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.	WWC2 WWC1	4.09e-05	2	223	2	29116649
Pubmed	Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?	TET2 SF3B1	4.09e-05	2	223	2	30587503
Pubmed	Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects.	NTM OPCML	4.09e-05	2	223	2	24616287
Pubmed	Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.	KIT FLT3	4.09e-05	2	223	2	9620281
Pubmed	Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice.	NOS3 LEPR	4.09e-05	2	223	2	22785174
Pubmed	Resveratrol induces mitochondrial biogenesis in endothelial cells.	NOS3 LEPR	4.09e-05	2	223	2	19429820
Pubmed	Creatine kinase transcript accumulation: effect of nerve during muscle development.	CKB CKM	4.09e-05	2	223	2	10417818
Pubmed	Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor.	NOS3 LEPR	4.09e-05	2	223	2	37288304
Pubmed	Telomere shortening in the esophagus of Japanese alcoholics: relationships with chromoendoscopic findings, ALDH2 and ADH1B genotypes and smoking history.	ALDH2 ALDH1B1	4.09e-05	2	223	2	23667679
Pubmed	Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL.	KIT FLT3	4.09e-05	2	223	2	22751451
Pubmed	KIBRA promotes prostate cancer cell proliferation and motility.	WWC2 WWC1	4.09e-05	2	223	2	27220053
Pubmed	ISX is a retinoic acid-sensitive gatekeeper that controls intestinal beta,beta-carotene absorption and vitamin A production.	LRAT BCO1	4.09e-05	2	223	2	20061533
Pubmed	Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice.	FANCD2 ALDH2	4.09e-05	2	223	2	21734703
Pubmed	Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling.	NOS3 LEPR	4.09e-05	2	223	2	25852084
Pubmed	Polarized PtdIns(4,5)P2 distribution mediated by a voltage-sensing phosphatase (VSP) regulates sperm motility.	TPTE TPTE2	4.09e-05	2	223	2	31776261
Pubmed	The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.	KIT DNMT1	4.09e-05	2	223	2	26085088
Pubmed	Yin Yang 1 promotes hepatic gluconeogenesis through upregulation of glucocorticoid receptor.	YY1 LEPR	4.09e-05	2	223	2	23193188
Pubmed	Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.	NOS3 LEPR	4.09e-05	2	223	2	16971655
Pubmed	Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions.	USP7 DNMT1	4.09e-05	2	223	2	34500587
Pubmed	Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3.	ITGAV CCR7	4.09e-05	2	223	2	21347514
Pubmed	The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.	CKB CKM	4.09e-05	2	223	2	19337554
Pubmed	[Regulation of Wnt/beta-catenin signaling by receptor tyrosine kinases in hematological malignancy].	KIT FLT3	4.09e-05	2	223	2	19915372
Pubmed	Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation.	USP7 DNMT1	4.09e-05	2	223	2	25960197
Pubmed	Ventricular arrhythmias in mouse models of diabetic kidney disease.	NOS3 LEPR	4.09e-05	2	223	2	34663875
Pubmed	Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.	KIT FLT3	4.09e-05	2	223	2	20039765
Pubmed	Loss of flk-2/flt3 expression during commitment of multipotent mouse hematopoietic progenitor cells to the mast cell lineage.	KIT FLT3	4.09e-05	2	223	2	9216738
Pubmed	Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling.	NOS3 NOX1	4.09e-05	2	223	2	20639222
Pubmed	Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.	FANCD2 TEX15	4.09e-05	2	223	2	28386063
Pubmed	Creatine kinase in non-muscle tissues and cells.	CKB CKM	4.09e-05	2	223	2	7808454
Pubmed	Approaching the multifaceted nature of energy metabolism: inactivation of the cytosolic creatine kinases via homologous recombination in mouse embryonic stem cells.	CKB CKM	4.09e-05	2	223	2	7808458
Pubmed	Comparison of diabetic nephropathy between male and female eNOS-/-db/db mice.	NOS3 LEPR	4.09e-05	2	223	2	30810354
Pubmed	Enhanced Nox1 expression and oxidative stress resistance in c-kit-positive hematopoietic stem/progenitor cells.	KIT NOX1	4.09e-05	2	223	2	25451257
Pubmed	A dynamic role of HAUSP in the p53-Mdm2 pathway.	MDM2 USP7	4.09e-05	2	223	2	15053880
Pubmed	PRDM12 Is Transcriptionally Active and Required for Nociceptor Function Throughout Life.	AVIL PRDM12	4.09e-05	2	223	2	34646120
Pubmed	Social defeat stress exacerbates atopic dermatitis through downregulation of DNA methyltransferase 1 and upregulation of C-C motif chemokine receptor 7 in skin dendritic cells.	CCR7 DNMT1	4.09e-05	2	223	2	32819567
Pubmed	Diagnostic significance of total creatine kinase and its isoform in tubal ectopic pregnancy.	CKB CKM	4.09e-05	2	223	2	23876027
Pubmed	Intron-less processed Pcdhalpha genes in the central nervous system.	PCDHA8 PCDHA6	4.09e-05	2	223	2	14697259
Pubmed	Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.	NOS3 LEPR	4.09e-05	2	223	2	23139354
Pubmed	Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2.	ALDH2 ALDH1B1	4.09e-05	2	223	2	23247008
Pubmed	Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.	PLCG1 KIT	4.09e-05	2	223	2	1714377
Pubmed	KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.	KIT FLT3	4.09e-05	2	223	2	18977345
Pubmed	Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.	TET2 SF3B1	4.09e-05	2	223	2	27622333
Pubmed	MYPT1 reduction is a pathogenic factor of erectile dysfunction.	PPP1R12A LEPR	4.09e-05	2	223	2	35879418
Pubmed	ZNF16 (HZF1) promotes erythropoiesis and megakaryocytopoiesis via regulation of the c-KIT gene.	KIT ZNF16	4.09e-05	2	223	2	24180487
Pubmed	CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.	KIT FLT3	4.09e-05	2	223	2	22261446
Pubmed	Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT strategy.	PLCG1 LEPR	4.09e-05	2	223	2	16698021
Pubmed	Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.	TET2 FLT3	4.09e-05	2	223	2	30651561
Pubmed	OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.	NTM OPCML	4.09e-05	2	223	2	12819783
Pubmed	High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity.	COL6A3 LEPR	4.09e-05	2	223	2	37302692
Pubmed	Targeting RIPK1 in AML cells carrying FLT3-ITD.	RIPK1 FLT3	4.09e-05	2	223	2	30828789
Pubmed	Mapping Transgene Insertion Sites Reveals Complex Interactions Between Mouse Transgenes and Neighboring Endogenous Genes.	FAT4 CDH6	4.09e-05	2	223	2	30405348
Pubmed	Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis.	FREM2 FRAS1	4.09e-05	2	223	2	21900877
Pubmed	Synergistic association between two alcohol metabolism relevant genes and coronary artery disease among Chinese hypertensive patients.	ALDH2 ALDH1B1	4.09e-05	2	223	2	25047496
Interaction	XAGE1A interactions	ADGRV1 MDM2 FREM2 FAT1 FAT4 FRAS1 FLT3 FAT3 YY1 CELSR2	1.79e-11	41	222	10	int:XAGE1A
Interaction	C2CD4B interactions	ADGRV1 FREM2 FAT1 FAT4 FRAS1 FAT3 AGGF1 CELSR2	2.41e-08	44	222	8	int:C2CD4B
Interaction	CD160 interactions	ADGRV1 ITGAV FAT1 FAT4 FAT3 CELSR2 TTC17 PCDH1	4.94e-08	48	222	8	int:CD160
Interaction	NXPH2 interactions	ADGRV1 FREM2 FAT1 FAT4 FRAS1 CELSR2 PCDH1	6.00e-08	33	222	7	int:NXPH2
Interaction	IFNE interactions	NAGLU ADGRV1 FAT1 FAT4 FRAS1 PCDH1	4.07e-07	27	222	6	int:IFNE
Interaction	LOC254896 interactions	ADGRV1 FREM2 FAT1 NRBP1 FAT4 FAT3 CELSR2	4.12e-07	43	222	7	int:LOC254896
Interaction	DCANP1 interactions	FREM2 FAT1 FAT4 FAT3 CELSR2	1.59e-06	19	222	5	int:DCANP1
Interaction	CC2D1B interactions	CKM FAT4 FAT3 CELSR2 NEMF PLCH1	3.43e-06	38	222	6	int:CC2D1B
Interaction	DKKL1 interactions	ADGRV1 FREM2 FAT1 RAD51B FAT4 FRAS1 FAT3 CELSR2 PCDH1	3.88e-06	111	222	9	int:DKKL1
Interaction	UCN3 interactions	ADGRV1 FREM2 FAT1 FAT4 FAT3	4.44e-06	23	222	5	int:UCN3
Interaction	PSG8 interactions	ADGRV1 FREM2 FAT1 FAT4 FRAS1 CELSR2	5.44e-06	41	222	6	int:PSG8
Interaction	ADAMTS13 interactions	FREM2 FAT4 FAT3 AGGF1 CELSR2	8.45e-06	26	222	5	int:ADAMTS13
Interaction	CMA1 interactions	ADGRV1 FREM2 FAT1 FAT4 FRAS1 CELSR2	1.08e-05	46	222	6	int:CMA1
Interaction	ZBBX interactions	FREM2 USP7 FAT4 FAT3 CELSR2	2.09e-05	31	222	5	int:ZBBX
Interaction	LAG3 interactions	ADGRV1 FREM2 FAT1 CELSR2	3.05e-05	17	222	4	int:LAG3
Interaction	TAFA5 interactions	ADGRV1 FREM2 USP7 FAT4	3.88e-05	18	222	4	int:TAFA5
Interaction	NPIPB6 interactions	KIF14 GAPDHS RGPD5 RGPD8	3.88e-05	18	222	4	int:NPIPB6
Interaction	CSTL1 interactions	ADGRV1 FAT4 FRAS1 CELSR2 TTC17 EPHA7	4.19e-05	58	222	6	int:CSTL1
Interaction	DCDC1 interactions	TAF1 DYNC1I1 FAT4 FAT3	4.88e-05	19	222	4	int:DCDC1
Interaction	CCL19 interactions	ADGRV1 CCR7 FAT4 KDM4A	4.88e-05	19	222	4	int:CCL19
Interaction	LINC02370 interactions	MAP1A UNC13B AKAP9	7.09e-05	8	222	3	int:LINC02370
Interaction	SSX6P interactions	MDM2 FAT3 CELSR2	7.09e-05	8	222	3	int:SSX6P
Interaction	ADAMTS17 interactions	ADGRV1 FREM2 FRAS1 CELSR2	7.40e-05	21	222	4	int:ADAMTS17
Interaction	PCDHA6 interactions	FLT3 PCDHA8 PCDHA6	1.05e-04	9	222	3	int:PCDHA6
Interaction	PCDHA1 interactions	FLT3 PCDHGB1 PCDHA8	1.05e-04	9	222	3	int:PCDHA1
Interaction	MYO1F interactions	LRRK2 FANCD2 USP7 KIF14 AVIL	1.06e-04	43	222	5	int:MYO1F
Interaction	YWHAE interactions	KIF21B TET2 ARL2BP RAPGEF6 PPP1R12A HLA-DRB1 LRRK2 SPATA18 ITGA2B CKB FANCD2 WWC2 KIF14 MAP3K15 ALDH2 ALDH1B1 WWC1 DNMT1 CALR DOCK9 USP43 OBSL1 USP46 SF3B1 AKAP9 GUCA1B SH3PXD2A TTC17 PLCH1	1.29e-04	1256	222	29	int:YWHAE
Interaction	MYBPC2 interactions	DYSF FLNB FLNC AMPD1 COL12A1	1.32e-04	45	222	5	int:MYBPC2
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	RAPGEF6 BRD8 PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6 ARAP3 PCDH1	1.72e-05	298	223	9	chr5q31
Cytoband	5q31	BRD8 PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6	2.22e-05	115	223	6	5q31
Cytoband	11q25	NTM GLB1L3 OPCML	2.71e-04	26	223	3	11q25
Cytoband	Ensembl 112 genes in cytogenetic band chr11q25	NTM GLB1L3 OPCML	4.60e-04	31	223	3	chr11q25
Cytoband	Ensembl 112 genes in cytogenetic band chr4q12	SPATA18 SRP72 KIT USP46	7.71e-04	84	223	4	chr4q12
GeneFamily	Cadherin related	FAT1 FAT2 PCDH15 FAT4 FAT3	2.55e-07	17	156	5	24
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	NASP SRP72 GTF3C3 TRANK1 PEX5 RGPD5 RGPD8 TTC17	6.95e-06	115	156	8	769
GeneFamily	Clustered protocadherins	PCDHGB1 PCDHB10 PCDHB6 PCDHA8 PCDHA6	2.27e-04	64	156	5	20
GeneFamily	C2 and WW domain containing	WWC2 WWC1	4.39e-04	4	156	2	838
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCG1 PLCH1 PLCE1	5.52e-04	19	156	3	832
GeneFamily	C2 tensin-type domain containing\|PTEN protein phosphatases\|Phosphoinositide phosphatases	TPTE TPTE2	7.27e-04	5	156	2	902
GeneFamily	I-set domain containing\|IgLON cell adhesion molecules	NTM OPCML	7.27e-04	5	156	2	1052
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	TPTE TPTE2	2.00e-03	8	156	2	837
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	WAPL PPP1R12A FAT1 FAT2 KIF14 WWC1 DOCK9 SMC4 ZHX2 EDRF1 DOP1A	4.70e-08	145	222	11	M1810
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	WAPL PPP1R12A FAT1 FAT2 BRD8 KIF14 WWC1 NEMP1 DOCK9 SMC4 ZHX2 AKAP9 EDRF1 DOP1A	3.10e-07	300	222	14	M8702
Coexpression	LIU_PROSTATE_CANCER_DN	PPP1R12A HLA-E SPATA18 ACOX2 NID1 C1S ALDH2 PLEKHH2 KIT NEMP1 FLNC ANK2 CELSR2 SH3PXD2A RAVER2 SEMA3E EPHA7	1.18e-06	493	222	17	M19391
Coexpression	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN	LRRK2 PPM1M GPR179 CKB FANCD2 FLT3 NRF1 SMC4 KIF20B LY75	2.02e-06	170	222	10	M6762
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP	PSMB1 LRRK2 PPM1M CKB KIT FLT3 SEMA7A SMC4 GTF3C6 LY75	4.11e-06	184	222	10	M6756
Coexpression	PUJANA_ATM_PCC_NETWORK	KIF21B ZNF862 NASP SRP72 ITGA2B MDM2 BFSP1 KCNH1 CRLF3 CLTB PLCG1 TAF1 ALOX5 ASF1A DNMT1 NEMP1 FLT3 SMC4 AGGF1 ARHGEF18 ZHX2 YY1 KIF20B OPCML TFDP1 SF3B1 KDM4A PRMT3 LY75	7.52e-06	1394	222	29	M9585
Coexpression	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP	DCAF6 RAPGEF6 CRLF3 CCR7 AMPD1 SH3PXD2A RAVER2 RNF38 PRMT3	1.28e-05	166	222	9	M7009
Coexpression	ONKEN_UVEAL_MELANOMA_UP	PCGF2 PPP1R12A HLA-DRB1 PSMB1 HLA-E NASP ZEB2 PTPRA ALG5 KIF14 KIT ASF1A FLNC ANK2 CALR DOCK9 AKAP9 MRPL15 RCBTB1 AACS	1.44e-05	790	222	20	M12490
Coexpression	GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN	DCAF6 RAPGEF6 CRLF3 CCR7 AMPD1 ADAMTS10 SH3PXD2A RNF38 PRMT3	1.78e-05	173	222	9	M2953
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	TET2 NASP MIA2 PEX5 TAF1 WWC1 DNMT1 FLNC FAT4 FRAS1 CALR TFDP1 AKR7A3 LRATD2 EPHA7	1.80e-05	484	222	15	MM999
Coexpression	STK33_SKM_DN	PCGF2 LRRK2 ACOX2 NID1 KIT ALOX5 FLT3 OBSL1 TEX15 LRATD2 PLCH1	2.56e-05	276	222	11	M2856
Coexpression	PUJANA_CHEK2_PCC_NETWORK	NAP1L4 NASP SRP72 AGL C1D KIF14 NUP160 ASF1A DNMT1 NEMP1 SMC4 YY1 KIF20B TFDP1 THOP1 NOX1 KDM4A PRMT3 SNRNP200	2.87e-05	761	222	19	M11961
Coexpression	STK33_NOMO_DN	LRRK2 TIGD1 ACOX2 CCR7 MAP3K15 KIT ALOX5 FLT3 OBSL1 TEX15 PLCH1	3.12e-05	282	222	11	M2854
Coexpression	ODONNELL_METASTASIS_UP	FAT1 PCDHB6 TDRD1 BCO1 CIDEC CDH6	4.60e-05	76	222	6	M265
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	TET2 NASP MIA2 PEX5 TAF1 WWC1 DNMT1 FLNC FAT4 FRAS1 CALR TFDP1 LRATD2 EPHA7	4.92e-05	467	222	14	M1347
Coexpression	GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	MDM2 FOXRED2 KIT FLNB GLB1L3 ARHGEF18 VTI1A GUCA1B RCBTB1	5.33e-05	199	222	9	M7985
Coexpression	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	NASP ASF1A DNMT1 SMC4 TFDP1	1.03e-04	55	222	5	M2180
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL	KIF21B ZNF442 BFSP1 FANCD2 C5orf34 KIF14 ATP11C ALDH1B1 KIT ANK2 FAT3 USP43 SUV39H2 LRP2 CDH6	1.08e-04	567	222	15	M45692
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 ADGRV1 FREM2 FAT1 TRANK1 PCDH15 FAT4 FRAS1 COL12A1 FAT3 LRP2 PLCH1 PLCE1 EPHA7	6.00e-13	184	223	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 ADGRV1 FREM2 FAT1 TRANK1 PCDH15 FAT4 FRAS1 COL12A1 FAT3 LRP2 PLCH1 PLCE1 EPHA7	6.00e-13	184	223	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 ADGRV1 FREM2 FAT1 TRANK1 PCDH15 FAT4 FRAS1 COL12A1 FAT3 LRP2 PLCH1 PLCE1 EPHA7	6.00e-13	184	223	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRAT XKR4 ADCY5 FAT1 WWC1 FRAS1 RHEX LRP2 CDH6 PLCE1 EPHA7	9.46e-10	168	223	11	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRAT LRRK2 FAT1 MIA2 DLG2 WWC1 ANK2 RHEX LRP2 CDH6 EPHA7	2.93e-09	187	223	11	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 DOCK9 LRP2 PLCH1	3.86e-09	192	223	11	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 DOCK9 LRP2 PLCH1	4.08e-09	193	223	11	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 DOCK9 LRP2 PLCH1	5.33e-09	198	223	11	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 FAT1 NTM GMDS DLG2 WWC1 FAT3 RHEX LRP2 EPHA7	2.82e-08	181	223	10	6956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ADGRV1 ADCY5 NTM WWC1 FRAS1 COL12A1 ANK2 RHEX EPHA7	2.97e-08	182	223	10	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 XKR4 FREM2 FAT1 NTM GMDS PLEKHH2 RHEX CDH6 EPHA7	3.65e-08	186	223	10	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ARHGEF38 XKR4 ADCY5 WWC1 FRAS1 USP43 ZHX2 CDH6 EPHA7	3.65e-08	186	223	10	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ARHGEF38 ADGRV1 XKR4 ADCY5 WWC1 USP43 ZHX2 CDH6 EPHA7	4.04e-08	188	223	10	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 XKR4 FAT1 NTM GMDS PLEKHH2 WWC1 FAT3 RHEX EPHA7	4.25e-08	189	223	10	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B FRAS1 USP43 LRP2 PLCH1 SEMA3E	4.25e-08	189	223	10	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ADGRV1 CKB FREM2 DLG2 WWC1 UNC13B FRAS1 PLCH1 SEMA3E	4.46e-08	190	223	10	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 UNC13B FMO5 DOCK9 LRP2 PLCH1	4.93e-08	192	223	10	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 LRP2 PLCH1	5.17e-08	193	223	10	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 LRP2 PLCH1	5.17e-08	193	223	10	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 LRP2 PLCH1	6.58e-08	198	223	10	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPP1R12A ADCY5 ZEB2 FAT1 NID1 PLEKHH2 COL6A3 PDE8B CDH6 PLCE1	7.23e-08	200	223	10	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYH6 SPATA18 ADGRV1 CHRNE CKM FAT2 COL6A3	1.09e-07	76	223	7	254d18bece2676faa4bbeb8d48b1d327ab3c2215
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYH6 SPATA18 ADGRV1 CHRNE CKM FAT2 COL6A3	1.09e-07	76	223	7	efbbbf91bca35720d8ecddb076f2c9f4de25e44d
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	LRAT XKR4 ADCY5 NTM RHEX LRP2 CDH6 PLCE1 EPHA7	2.24e-07	172	223	9	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ADGRV1 NTM WWC1 FRAS1 COL12A1 ANK2 RHEX EPHA7	3.45e-07	181	223	9	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 PLCH1	3.78e-07	183	223	9	6847c1252d6bb105524f812658112517fd351eab
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	HLA-E PCDH15 GMDS NOS3 FLNB DOCK9 LEPR OPCML ARAP3	4.54e-07	187	223	9	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 DOCK9 LRP2 PLCH1	4.96e-07	189	223	9	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|COVID-19_Convalescent / Disease condition and Cell class	ZMYND11 PPM1M PCYOX1L PEX5 GMDS NUP160 MRPL15 EDRF1 DOP1A	4.96e-07	189	223	9	732e8dcffcb634ca2968f9170c9c4b31dd5d4206
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	ARHGEF38 ADGRV1 FAT1 WWC1 RAD51B FRAS1 FAM83A SEMA3E EPHA7	5.19e-07	190	223	9	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B FRAS1 LRP2 PLCH1 SEMA3E	5.19e-07	190	223	9	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ADGRV1 FREM2 DLG2 WWC1 UNC13B DOCK9 PLCH1 EPHA7	5.42e-07	191	223	9	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 XKR4 FAT1 GMDS PLEKHH2 WWC1 FAT3 RHEX EPHA7	5.42e-07	191	223	9	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B FMO5 PLCH1	5.42e-07	191	223	9	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC2 DLG2 WWC1 UNC13B PLCH1	5.42e-07	191	223	9	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B LRP2 PLCH1	5.42e-07	191	223	9	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B FRAS1 ANK2 LRP2 PLCH1	5.66e-07	192	223	9	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 WWC1 UNC13B DOCK9 PLCH1	5.66e-07	192	223	9	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC2 NTM DLG2 WWC1 UNC13B	6.18e-07	194	223	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 UNC13B FMO5 DOCK9 PLCH1	6.18e-07	194	223	9	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B FRAS1 USP43 LRP2 PLCH1	6.18e-07	194	223	9	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	HLA-E PCDH15 GMDS NOS3 FLNB DOCK9 LEPR OPCML ARAP3	6.18e-07	194	223	9	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGEF38 ADGRV1 FAT1 WWC1 RAD51B FRAS1 SEMA3E PLCE1 EPHA7	6.45e-07	195	223	9	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC2 WWC1 UNC13B LRP2 PLCH1	7.64e-07	199	223	9	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HLA-DRB1 PPM1M DYSF CCR7 ALDH2 FLT3 RHEX LY75 HPS5	7.64e-07	199	223	9	c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HLA-DRB1 PPM1M DYSF CCR7 ALDH2 FLT3 RHEX LY75 HPS5	7.64e-07	199	223	9	b9613e88c4b752529d6ae20857744418207b0830
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NID1 C1S PLEKHH2 FLNB COL6A3 FAT4 COL12A1 ANK2 EPHA7	7.64e-07	199	223	9	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 ZEB2 NID1 C1S COL6A3 FAT4 COL12A1 ANK2 LEPR	7.96e-07	200	223	9	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 ZEB2 NID1 C1S COL6A3 FAT4 COL12A1 ANK2 LEPR	7.96e-07	200	223	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	TPTE KCNS1 PLEKHH2 FAT4 COL12A1 LEPR SEMA3E PLCE1	9.71e-07	151	223	8	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FAT1 WWC1 UNC13B FMO5 OBSL1	1.30e-06	157	223	8	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH6 ZEB2 PCYOX1L ALG5 COL6A3 TFDP1 CELSR2 ADAMTSL2	1.43e-06	159	223	8	330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH6 ZEB2 PCYOX1L ALG5 COL6A3 TFDP1 CELSR2 ADAMTSL2	1.43e-06	159	223	8	cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|368C / Donor, Lineage, Cell class and subclass (all cells)	HLA-DRB1 NAGLU ADCY5 ALDH2 ALOX5 ARHGEF18 CIDEC LY75	1.50e-06	160	223	8	ac3f56f8ab8efd11c4b4868a828db05c23ac762f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRAT LRRK2 FAT1 NTM WWC1 COL12A1 LRP2 EPHA7	1.81e-06	164	223	8	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A ZEB2 NID1 DYNC1I1 JAKMIP3 ADAMTS10 GUCA1B PLCE1	2.07e-06	167	223	8	bb53a478b5d821d6d82c15bc4ed075b67682457c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A ZEB2 NID1 DYNC1I1 JAKMIP3 ADAMTS10 GUCA1B PLCE1	2.07e-06	167	223	8	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A ZEB2 NID1 DYNC1I1 JAKMIP3 ADAMTS10 GUCA1B PLCE1	2.07e-06	167	223	8	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	ASK428-Immune-Mast_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	MAP1A FAT1 NTM KIT NOS3 ZHX2 RHEX VWA5A	2.16e-06	168	223	8	c399fcb4d1d0be48026c2ecabc34a5935e7adf73
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NAGLU ADGRV1 ADCY5 NID1 ARHGEF18 CIDEC SEMA3E PLCE1	2.47e-06	171	223	8	e59afa0a773dca3b9c208d17510ea55703b42598
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY5 CHRNE FREM2 PCDH15 COL6A3 FLNC AVIL LRP2	2.81e-06	174	223	8	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 FAT1 NTM GMDS PLEKHH2 FAT3 RHEX EPHA7	3.06e-06	176	223	8	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	LRRK2 ARHGEF38 ADGRV1 FREM2 DLG2 UNC13B LRP2 PLCH1	3.61e-06	180	223	8	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	3'_v3-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	ITGA2B NTM KIT ALOX5 OBSL1 TEX15 RHEX VWA5A	3.76e-06	181	223	8	30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
ToppCell	facs-GAT-Fat-3m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA18 ARHGEF38 ACOX2 MIA2 WWC1 RBP2 LRP2 PLCH1	3.76e-06	181	223	8	11cb84528f7ca084f0a92eda4f2e18e63a428fe9
ToppCell	facs-GAT-Fat-3m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA18 ARHGEF38 ACOX2 MIA2 WWC1 RBP2 LRP2 PLCH1	3.76e-06	181	223	8	e97cbaafb93fdbee8e3cf4a06e6bcf121d941403
ToppCell	facs-GAT-Fat-3m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPATA18 ARHGEF38 ACOX2 MIA2 WWC1 RBP2 LRP2 PLCH1	3.76e-06	181	223	8	5ffeca29e4d31a20c110d27af128ed024a79ad56
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 FAT1 NTM GMDS WWC1 FAT3 RHEX EPHA7	4.08e-06	183	223	8	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 FAT1 NTM GMDS WWC1 FAT3 RHEX EPHA7	4.08e-06	183	223	8	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XKR4 KCNH1 C1S DLG2 CCR7 ARHGEF18 AVIL	4.21e-06	130	223	7	e5acaa9aaa22b10d11410e2c01647b31354c21ed
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B LRP2 PLCH1	4.25e-06	184	223	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRAT XKR4 ADCY5 FAT1 NTM PLEKHH2 RHEX PLCE1	4.98e-06	188	223	8	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 XKR4 NTM GMDS PLEKHH2 WWC1 RHEX EPHA7	4.98e-06	188	223	8	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRAT XKR4 ADCY5 FAT1 NTM PLEKHH2 RHEX PLCE1	4.98e-06	188	223	8	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC2 WWC1 UNC13B PLCH1	4.98e-06	188	223	8	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 FREM2 WWC1 UNC13B FRAS1 USP43 LRP2 PLCH1	5.18e-06	189	223	8	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	PPM1M PCYOX1L PEX5 GMDS NUP160 MRPL15 EDRF1 DOP1A	5.18e-06	189	223	8	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRAT LRRK2 FAT1 WWC1 RHEX LRP2 CDH6 EPHA7	5.18e-06	189	223	8	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADCY5 FAT1 NID1 COL6A3 SYNM PDE8B CDH6 PLCE1	5.38e-06	190	223	8	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADCY5 FAT1 NID1 COL6A3 SYNM PDE8B CDH6 PLCE1	5.38e-06	190	223	8	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PCDH15 NID1 PLEKHH2 COL6A3 FAT4 FRAS1 ANK2 FAT3	5.59e-06	191	223	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGEF38 ADGRV1 FAT1 WWC1 RAD51B FRAS1 SEMA3E EPHA7	5.59e-06	191	223	8	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 ITGAV FAT1 WWC1 RHEX LRP2 CDH6 EPHA7	5.59e-06	191	223	8	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ADGRV1 CKB FREM2 WWC2 WWC1 UNC13B PLCH1	5.59e-06	191	223	8	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	LRRK2 ADGRV1 CKB FREM2 WWC2 WWC1 UNC13B CELSR2	5.59e-06	191	223	8	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC2 WWC1 UNC13B PLCH1	5.81e-06	192	223	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ADGRV1 CKB FREM2 WWC2 UNC13B SMC4 CELSR2	5.81e-06	192	223	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 KIF14 UNC13B USP43 LRP2 PLCH1	5.81e-06	192	223	8	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB2 NTM NID1 C1S DYNC1I1 COL6A3 COL12A1 ADAMTSL2	5.81e-06	192	223	8	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 CKB FREM2 WWC1 UNC13B USP43 LRP2 PLCH1	5.81e-06	192	223	8	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	HLA-E PCDH15 GMDS FLNB DOCK9 LEPR OPCML ARAP3	6.04e-06	193	223	8	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 FAT1 MIA2 NTM GMDS PLEKHH2 CDH6 EPHA7	6.04e-06	193	223	8	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT2 SERPINB11 GMDS ALOX5 FLNB SH3PXD2A SEMA3E PLCE1	6.04e-06	193	223	8	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTM PCDH15 C1S DLG2 PLEKHH2 COL6A3 ANK2 FAT3	6.04e-06	193	223	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B PLCH1 SEMA3E	6.04e-06	193	223	8	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTM PCDH15 C1S DLG2 PLEKHH2 COL6A3 ANK2 FAT3	6.27e-06	194	223	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTM PCDH15 C1S DLG2 PLEKHH2 COL6A3 ANK2 FAT3	6.27e-06	194	223	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 ADGRV1 FREM2 WWC1 UNC13B FRAS1 LRP2 PLCH1	6.27e-06	194	223	8	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 ARHGEF38 ADGRV1 WWC2 DLG2 WWC1 UNC13B PLCH1	6.51e-06	195	223	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	proximal-3-Hematologic-Basophil/Mast_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGA2B ZEB2 NTM KIT ALOX5 SEMA7A RHEX VWA5A	6.76e-06	196	223	8	1a5d0d2fee932f97614bf923686fdc2655c7ca75
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	PCGF2 MIA2 ALDH1B1 NUP160 ANK2 OBSL1 AGGF1 YY1 SUV39H2 THOP1 EDRF1	3.61e-06	196	221	11	2936_DN
Drug	3-dinitrobenzene	DCAF6 PSMB1 NID1 TAF1 ALDH2 GAPDHS NOS3 CALR OBSL1 ZHX2 TDRD1 ARAP3 ABCA5 AVIL AKR7A3	6.49e-06	388	221	15	ctd:C017906
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A	PPP1R12A ITGAV AGL PEX5 GMDS KCNS1 NUP160 YY1 KIF20B KDM4A	2.01e-05	193	221	10	1375_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	ZMYND11 DYSF FOXRED2 ALDH1B1 FLNB CALR SMC4 ZNF16 VWA5A EDRF1	2.20e-05	195	221	10	6174_DN
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A	MDM2 ZNF442 TUBGCP5 PTPRA MIA2 AMPD1 SUV39H2 VWA5A PLCH1 INPP5J	2.20e-05	195	221	10	3246_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	PSMB1 NAGLU MDM2 BFSP1 FOXRED2 PLCG1 DOCK9 PDE8B CIDEC SNTG1	2.30e-05	196	221	10	6744_DN
Drug	Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A	PCGF2 MAP1A ZNF862 FOXRED2 NSFL1C KCNS1 NUP160 ZNF16 AKAP9 CIDEC	2.40e-05	197	221	10	6487_DN
Drug	Ginkgolide A [15291-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A	PCGF2 MAP1A MDM2 FOXRED2 KCNS1 TAF1 SEMA7A NRF1 VWA5A INPP5J	2.51e-05	198	221	10	3260_UP
Drug	Nitrocaramiphen hydrochloride; Down 200; 10.8uM; HL60; HT_HG-U133A	TMPRSS15 KCNS1 ALDH2 ALDH1B1 NRF1 ELP1 SUV39H2 ARAP3 PDE8B CIDEC	2.62e-05	199	221	10	3125_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A	PCGF2 ZNF862 NAGLU TRANK1 USP7 FMO5 TEX15 OPCML PDE8B PLCH1	2.62e-05	199	221	10	4490_DN
Drug	Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A	ZNF442 KCNS1 AMPD1 FAT4 SEMA7A LEPR BCO1 ATP2A1 CDH6 INPP5J	2.62e-05	199	221	10	6093_UP
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; PC3; HT_HG-U133A	KIF21B ITGA2B MIA2 C1S CCR7 MVB12B TDRD1 PCDH1 SNRNP200 EPHA7	2.74e-05	200	221	10	4638_UP
Disease	Colorectal Carcinoma	TET2 ZNF442 ZEB2 FAT1 NID1 ATP11C ALDH2 UNC13B FLNC AMPD1 ANK2 CALR VTI1A ARAP3 AKAP9 ABCA5 LRP2 SNRNP200 EDRF1 EPHA7	2.15e-07	702	213	20	C0009402
Disease	neutrophil count, basophil count	TET2 HLA-DRB1 KIT NUP160 DNMT1 RAD51B FLT3 PCDHA8 PCDHA6 LEPR RCBTB1	7.79e-07	224	213	11	EFO_0004833, EFO_0005090
Disease	platelet crit	TET2 MAP1A LRRK2 HLA-E ITGA2B ADGRV1 ADCY5 CHRNE USP7 ALDH2 GAPDHS ALDH1B1 KIT NUP160 RAD51B FLT3 NRF1 RBP5 LEPR THOP1 LY75 PLCE1	1.75e-06	952	213	22	EFO_0007985
Disease	Hepatomegaly	PEPD ALDH1B1 NOS3 LEPR AKR7A3 ADAMTSL2	2.55e-06	54	213	6	C0019209
Disease	Squamous cell carcinoma of esophagus	FAT1 FAT2 ALDH2 FAT4 CALR FAT3 PLCE1	5.97e-06	95	213	7	C0279626
Disease	Malignant neoplasm of breast	TPTE SPATA18 ARHGEF38 MDM2 DYSF ZEB2 C5orf34 MIA2 KCNH1 KIT NOS3 DNMT1 RAD51B FLNB ANK2 ELP1 JAKMIP3 SUV39H2 LEPR ARAP3 AKAP9 DOP1A	1.18e-05	1074	213	22	C0006142
Disease	Adenocarcinoma	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0001418
Disease	Carcinoma, Granular Cell	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0205644
Disease	Adenocarcinoma, Tubular	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0205645
Disease	Adenocarcinoma, Oxyphilic	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0205642
Disease	Carcinoma, Cribriform	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0205643
Disease	Adenocarcinoma, Basal Cell	CKB NOS3 ALOX5 DNMT1 FAT4 VTI1A PLCE1	2.22e-05	116	213	7	C0205641
Disease	neutrophil count, eosinophil count	TET2 HLA-DRB1 KIT NUP160 DNMT1 RAD51B FLT3 LEPR RCBTB1	2.64e-05	213	213	9	EFO_0004833, EFO_0004842
Disease	acute myeloid leukemia (is_marker_for)	TET2 MDM2 DNMT1 FLT3 CALR	2.75e-05	49	213	5	DOID:9119 (is_marker_for)
Disease	descending aortic diameter	MYH6 C1D ALDH2 FLNB COL6A3 PLCE1	4.37e-05	88	213	6	EFO_0021788
Disease	Refractory anemia with ringed sideroblasts	TET2 SF3B1	5.19e-05	2	213	2	C1264195
Disease	spondylocarpotarsal synostosis syndrome (implicated_via_orthology)	MYH6 FLNB	5.19e-05	2	213	2	DOID:0090116 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_implicated_in)	TET2 MDM2 PLCG1 ALDH2 FLT3 CALR LEPR SF3B1	5.43e-05	181	213	8	DOID:684 (is_implicated_in)
Disease	sleep measurement	TET2 XKR4 NTM NUP160 NRF1 OPCML CDH6	5.87e-05	135	213	7	EFO_0004870
Disease	Adenocarcinoma of large intestine	RIPK1 MDM2 MAP3K15 TAF1 KIT EPHA7	7.12e-05	96	213	6	C1319315
Disease	granulocyte count	TET2 HLA-DRB1 KIT NUP160 DNMT1 RAD51B FLT3 LEPR RCBTB1	1.03e-04	254	213	9	EFO_0007987
Disease	glucose measurement	TET2 ADCY5 MAP3K15 PLCG1 ALDH2 PLEKHH2 NUP160 NRBP1 ELP1 AACS KDM4A	1.09e-04	380	213	11	EFO_0004468
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	1.55e-04	3	213	2	DOID:0080096 (implicated_via_orthology)
Disease	Cryptophthalmos syndrome	FREM2 FRAS1	1.55e-04	3	213	2	C0265233
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	1.55e-04	3	213	2	DOID:0111190 (implicated_via_orthology)
Disease	FRASER SYNDROME 1	FREM2 FRAS1	1.55e-04	3	213	2	C4551480
Disease	Disorder of eye	LRAT ADGRV1 GPR179 FREM2 PCDH15 FRAS1 GUCA1B SNRNP200	1.63e-04	212	213	8	C0015397
Disease	mean platelet volume	TET2 LRRK2 ITGA2B CHRNE PCYOX1L BRD8 TRANK1 CRLF3 USP7 KCNS1 NID1 NOS3 ASF1A RAD51B NRF1 PCDHGB1 LEPR LY75 PLCE1	1.65e-04	1020	213	19	EFO_0004584
Disease	myeloid white cell count	TET2 HLA-DRB1 PEPD NAP1L4 ADCY5 PTPRA ALDH1B1 KIT NUP160 DNMT1 RAD51B FLNB FLT3 LEPR RCBTB1 LRATD2 LY75 PLCE1	1.69e-04	937	213	18	EFO_0007988
Disease	FEV/FEC ratio	TET2 ARHGEF38 NASP ITGAV ZEB2 FREM2 WWC2 C5orf34 NTM CRLF3 C1D GMDS RAD51B COL6A3 FRAS1 DOCK9 ARHGEF18 YY1 NETO1 SH3PXD2A RNF38	2.39e-04	1228	213	21	EFO_0004713
Disease	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	TET2 KIT	3.08e-04	4	213	2	C1301365
Disease	Ullrich congenital muscular dystrophy 1	COL6A3 COL12A1	3.08e-04	4	213	2	C0410179
Disease	vulva cancer (is_implicated_in)	HLA-DRB1 NOS3	3.08e-04	4	213	2	DOID:1245 (is_implicated_in)
Disease	Bethlem myopathy (is_implicated_in)	COL6A3 COL12A1	3.08e-04	4	213	2	DOID:0050663 (is_implicated_in)
Disease	Myelofibrosis	TET2 CALR	3.08e-04	4	213	2	C0026987
Disease	Fraser syndrome (implicated_via_orthology)	FREM2 FRAS1	3.08e-04	4	213	2	DOID:0090001 (implicated_via_orthology)
Disease	Ullrich congenital muscular dystrophy	COL6A3 COL12A1	3.08e-04	4	213	2	cv:C4551860
Disease	Bethlem myopathy	COL6A3 COL12A1	3.08e-04	4	213	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A3 COL12A1	3.08e-04	4	213	2	C1834674
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A3 COL12A1	3.08e-04	4	213	2	DOID:0050558 (is_implicated_in)
Disease	post-traumatic stress disorder symptom measurement	ADCY5 RAD51B PCDHA8 PCDHA6 OPCML	3.25e-04	82	213	5	EFO_0008535
Disease	acute myeloid leukemia (is_implicated_in)	TET2 ITGAV KIT NOS3 FLT3	3.63e-04	84	213	5	DOID:9119 (is_implicated_in)
Disease	response to anticonvulsant	NID1 COL6A3 ANK2 LEPR CDH6	3.84e-04	85	213	5	GO_0036277
Disease	Myelodysplastic syndrome	TET2 SF3B1	5.11e-04	5	213	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	TET2 SF3B1	5.11e-04	5	213	2	614286
Disease	ileus (biomarker_via_orthology)	KIT NOS3	5.11e-04	5	213	2	DOID:8440 (biomarker_via_orthology)
Disease	sick sinus syndrome (is_implicated_in)	MYH6 ANK2	5.11e-04	5	213	2	DOID:13884 (is_implicated_in)
Disease	Acute myelomonocytic leukemia	KIT FLT3	5.11e-04	5	213	2	C0023479
Disease	serum alanine aminotransferase measurement	RAPGEF6 HLA-DRB1 SPATA18 PEPD TRANK1 NUP160 ALOX5 DNMT1 RAD51B COL12A1 LEPR CELSR2 MPND CDH6 SEMA3E PLCE1	6.15e-04	869	213	16	EFO_0004735
Disease	Acute Cerebrovascular Accidents	ITGA2B ITGAV ANK2 SH3PXD2A	6.29e-04	54	213	4	C0751956
Disease	stroke	FAT2 ALDH2 NOS3 ANK2 SH3PXD2A EPHA7	6.43e-04	144	213	6	EFO_0000712
Disease	beta-aminoisobutyric acid measurement	SEMA7A ARAP3 PCDH1	6.71e-04	24	213	3	EFO_0010464
Disease	Bipolar Disorder	HLA-DRB1 HLA-E TRANK1 DLG2 PLCG1 ALDH2 NOS3 DNMT1 CALR DOCK9 USP46	7.47e-04	477	213	11	C0005586
Disease	Eye Diseases, Hereditary	LRAT LRP2	7.63e-04	6	213	2	C0015398
Disease	Primary Myelofibrosis	TET2 CALR	7.63e-04	6	213	2	C0001815
Disease	cerebellum cortex volume change measurement, age at assessment	WWC1 MVB12B PLCH1	8.53e-04	26	213	3	EFO_0008007, EFO_0021497
Disease	methionine measurement	ADGRV1 PCDH15 NID1	8.53e-04	26	213	3	EFO_0009771
Disease	migraine disorder, pulse pressure measurement	C1D DNAJA3 PLCE1	8.53e-04	26	213	3	EFO_0005763, MONDO_0005277
Disease	aspartate aminotransferase measurement	KIF21B RAPGEF6 HLA-DRB1 PEPD NAP1L4 ACOX2 CKB CKM WWC2 ALDH2 NUP160 FLNB LEPR OPCML LY75 PLCE1	9.32e-04	904	213	16	EFO_0004736
Disease	Retinitis Pigmentosa	LRAT ARL2BP ARHGEF18 GUCA1B SNRNP200	9.64e-04	104	213	5	C0035334
Disease	lymphocyte count	TET2 HLA-DRB1 SPATA18 PEPD ADCY5 C5orf34 CRLF3 USP7 CCR7 ALDH1B1 NUP160 DNMT1 RAD51B FLNB FRAS1 FLT3 PCDHGB1 ARHGEF18 PCDHA6 TDRD1 LEPR PLCE1	9.66e-04	1464	213	22	EFO_0004587
Disease	Cerebrovascular accident	ITGA2B ITGAV ANK2 SH3PXD2A	1.06e-03	62	213	4	C0038454
Disease	Hereditary retinal dystrophy	ARL2BP PCDH15	1.06e-03	7	213	2	C0154860
Disease	anxiety, vitamin D measurement	VTI1A SEMA3E	1.06e-03	7	213	2	EFO_0004631, EFO_0005230
Disease	retinopathy of prematurity (is_implicated_in)	HLA-DRB1 NOS3	1.06e-03	7	213	2	DOID:13025 (is_implicated_in)
Disease	urinary bladder cancer (is_marker_for)	MDM2 KIT NOS3 DNMT1 KDM4A	1.09e-03	107	213	5	DOID:11054 (is_marker_for)
Disease	oral squamous cell carcinoma (is_marker_for)	TET2 PLCG1 FLT3 CALR	1.13e-03	63	213	4	DOID:0050866 (is_marker_for)
Disease	carcinoma (implicated_via_orthology)	DLG2 KIT FAT4 FLT3	1.20e-03	64	213	4	DOID:305 (implicated_via_orthology)
Disease	fasting blood glucose measurement	ADCY5 GMDS ALDH2 FAT3 ELP1 PRDM5 LEPR ARAP3	1.20e-03	287	213	8	EFO_0004465
Disease	platelet component distribution width	LRRK2 NAP1L4 ITGA2B ADCY5 CHRNE CKB BRD8 TRANK1 MIA2 CRLF3 USP7 NOS3 NRF1 DOCK9	1.25e-03	755	213	14	EFO_0007984
Disease	Unilateral agenesis of kidney	FREM2 FRAS1	1.41e-03	8	213	2	C0266294
Disease	interleukin-21 measurement	HLA-DRB1 C1S	1.41e-03	8	213	2	EFO_0801724
Disease	MYELODYSPLASTIC SYNDROME	TET2 FANCD2 CALR SF3B1	1.42e-03	67	213	4	C3463824
Disease	venous thromboembolism, fibrinogen measurement	RAPGEF6 LEPR PARP10 TTC17	1.42e-03	67	213	4	EFO_0004286, EFO_0004623
Disease	lifestyle measurement	TET2 NTM PCDH15 WWC1 ARAP3 ATP2A1 PCDH1	1.66e-03	235	213	7	EFO_0010724
Disease	Acute Coronary Syndrome	PSMB1 CKB CKM	1.72e-03	33	213	3	C0948089
Disease	glycoprotein measurement	HLA-DRB1 ADGRV1 MIA2 PLCG1 LEPR	1.75e-03	119	213	5	EFO_0004555
Disease	low tension glaucoma	GMDS FLNB	1.81e-03	9	213	2	EFO_1001022
Disease	Malignant neoplasm of prostate	TET2 DCAF6 NAGLU SPATA18 MDM2 USP7 NOS3 ALOX5 DNMT1 CALR SF3B1 LRP2	1.84e-03	616	213	12	C0376358
Disease	Prostatic Neoplasms	TET2 DCAF6 NAGLU SPATA18 MDM2 USP7 NOS3 ALOX5 DNMT1 CALR SF3B1 LRP2	1.84e-03	616	213	12	C0033578
Disease	cardiovascular disease	WAPL CKB GMDS DLG2 CCR7 NOS3 DNMT1 ARHGEF18 CELSR2 PLCE1	1.90e-03	457	213	10	EFO_0000319
Disease	response to alcohol	WWC2 PCDH15 ALDH2 PRMT3	2.15e-03	75	213	4	EFO_0005526
Disease	intellectual disability (implicated_via_orthology)	PSMB1 ITGA2B ITGAV ANK2	2.15e-03	75	213	4	DOID:1059 (implicated_via_orthology)
Disease	alopecia areata (is_marker_for)	DNMT1 KDM4A	2.25e-03	10	213	2	DOID:986 (is_marker_for)
Disease	age at menarche, spine bone mineral density	KCNH1 PCDH15	2.25e-03	10	213	2	EFO_0004703, EFO_0007701
Disease	Malignant Neoplasms	MDM2 KIT NOS3 YY1 SF3B1	2.41e-03	128	213	5	C0006826
Disease	body weights and measures	GMDS ADAMTS10 EPHA7	2.60e-03	38	213	3	EFO_0004324
Disease	coronary artery disease	TET2 XKR4 ZEB2 CKB C1D GMDS C1S PLCG1 ALDH2 PLEKHH2 NOS3 NUP160 COL6A3 FAT4 DOCK9 USP43 CELSR2 PLCE1	2.70e-03	1194	213	18	EFO_0001645
Disease	Asthma	HLA-DRB1 ALDH2 ALOX5 DNMT1	2.72e-03	80	213	4	C0004096
Disease	obstructive sleep apnea (is_implicated_in)	NOS3 LEPR	2.73e-03	11	213	2	DOID:0050848 (is_implicated_in)
Disease	birth weight, parental genotype effect measurement	TET2 ADCY5 NOS3 DNMT1 ARAP3 PLCE1	2.79e-03	192	213	6	EFO_0004344, EFO_0005939
Disease	lung cancer (is_marker_for)	DNMT1 CALR KDM4A	2.80e-03	39	213	3	DOID:1324 (is_marker_for)
Disease	Pulmonary Hypertension	NOS3 ALOX5 LEPR	3.01e-03	40	213	3	C0020542
Disease	Juvenile-Onset Still Disease	HLA-DRB1 ITGA2B DYSF TFDP1 UBE3C	3.04e-03	135	213	5	C0087031
Disease	retinitis pigmentosa (is_implicated_in)	LRAT ARHGEF18 SNRNP200	3.23e-03	41	213	3	DOID:10584 (is_implicated_in)
Disease	acute myeloid leukemia (implicated_via_orthology)	FLT3 SF3B1	3.26e-03	12	213	2	DOID:9119 (implicated_via_orthology)
Disease	autoimmune thyroiditis (is_implicated_in)	HLA-DRB1 LRP2	3.26e-03	12	213	2	DOID:7188 (is_implicated_in)
Disease	granulins measurement	ITGA2B CELSR2	3.26e-03	12	213	2	EFO_0008141
Disease	distal myopathy (implicated_via_orthology)	MYH6 DYSF	3.26e-03	12	213	2	DOID:11720 (implicated_via_orthology)
Disease	abdominal aortic aneurysm (is_implicated_in)	HLA-DRB1 ITGAV	3.26e-03	12	213	2	DOID:7693 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HFVDYGNIEEVTADE	TDRD1	796	Q9BXT4
QVFLGDYSSETSEDD	ABCA5	1356	Q8WWZ7
GFLAESEEDYAETIA	ALG11	436	Q2TAA5
ETEATYDAATQEFVI	ACOX2	166	Q99424
EEEFGVDDSYSEQGA	AKAP9	136	Q99996
YSAEDRDETFVQDGS	ADAM5	316	Q6NVV9
NTEAGTEDYEDLTQA	ARHGEF18	616	Q6ZSZ5
SAYQAVEVDRQFDGA	AVIL	456	O75366
IDGYISVFDIDSDQV	ARAP3	1081	Q8WWN8
TEIDTAFVYSEGQSE	AKR7A3	41	O95154
FVVEQVESYDEAGDS	DNMT1	556	P26358
DIAVSYTGEELDFET	BRD8	401	Q9H0E9
FGSSEIYNIVESFEE	AACS	551	Q86V21
FTYEVIVVDDGSKDQ	ALG5	101	Q9Y673
AGSRTFVEESIYNEF	ALDH1B1	321	P30837
DVDSFQEVDEQIFYA	ARHGEF38	706	Q9NXL2
GSAESEEYDQVLDSV	ASF1A	46	Q9Y294
GEIEYEIINGDTDTF	FAT4	1561	Q6V0I7
ITYIVNEDDEDGIFF	FAT4	1876	Q6V0I7
AIAGEDYSIASSDVV	ADGRV1	2161	Q8WXG9
DAQGYAAVLTVEASD	ADGRV1	2806	Q8WXG9
DEVTDDYIGDNTTVD	CCR7	26	P32248
SYDEAITSEGNVTAE	AGGF1	381	Q8N302
GFTEFIQYQADRTDD	DOP1A	601	Q5JWR5
TGDYASGVTVEDFEI	AMPD1	121	P23109
ATDEDTGENARITYF	CELSR2	736	Q9HCU4
DADTGAVTTQAELDY	CELSR2	761	Q9HCU4
YAFVGFDVIAASSEE	SLC7A4	246	O43246
GDGVIFYTNVEQDAE	DCAF6	116	Q58WW2
SEFYVELEANNEGVE	ADCY5	1081	O95622
ASDAEFDAVVGYLED	ARL2BP	16	Q9Y2Y0
IFGENEEVADRAYTG	ATP2A1	641	O14983
EGFNFYTERAAAVVD	ADAMTS10	646	Q9H324
YNAEEVEFTFAVDND	CHRNE	171	Q04844
RAAAVSEAEADFYEQ	NAGLU	626	P54802
GAVVYIDTESAFSAE	RAD51B	136	O15315
ASEALYVTDNDEVFV	RCBTB1	31	Q8NDN9
VGGFAVVEYSTAEQA	RAVER2	271	Q9HCJ3
RNFVAVYDGSSSVED	NETO1	231	Q8TDF5
LEDDVSAVEFRQTGY	NOMO3	576	P69849
YAVDDVQYVDEIASV	PEPD	121	P12955
SVVTQEEERDGQYFE	RGPD5	1321	Q99666
SVVTQEEERDGQYFE	RGPD8	1321	O14715
AAGEQDVFYEVSLDN	GOLGA6A	646	Q9NYA3
EGENIFYLAVEDIET	PRDM5	101	Q9NQX1
EYEVRIFENADNGTT	PCDHA6	246	Q9UN73
IVSEEDISVGYSTFQ	ANK2	3711	Q01484
GTASEDVFQYEVAVL	NOX1	386	Q9Y5S8
QVYDGEDAVFSLDLS	OBSL1	626	O75147
GSNADITYAIEADSE	FAT1	2626	Q14517
AVLYFTGEAIEDDDN	NAP1L4	331	Q99733
DFFGQSYDEERTIAD	KIF14	1251	Q15058
LEDDVSAVEFRQTGY	NOMO2	576	Q5JPE7
EYEVRIFENADNGTT	PCDHA8	246	Q9Y5H6
VGYVDDTQFVRFDND	HLA-E	46	P13747
LAEAGFLDDVVYDST	FRAS1	3386	Q86XX4
AEYDSVVAAVQEGAA	MAP1A	1881	P78559
DRIVDFQFGSDEAAY	NEMF	96	O60524
ISFDLAEYTADVDGV	GMDS	116	O60547
NDGENVDLIVEYEAF	KIT	326	P10721
AVGFVSEDEYLEIQG	NTM	176	Q9P121
TEDSGQVAFEAQYEE	GPR179	2341	Q6PRD1
TVGCVAGDEESYEVF	CKB	71	P12277
AVSDESVAGDSGVYE	WWC1	621	Q8IX03
YDFIDSVGNDVDVVS	EDRF1	111	Q3B7T1
GIVTSYDYDAVLTEA	GLB1L3	361	Q8NCI6
VGSNDFENAVLDYVI	SPATA18	366	Q8TC71
LIESDESDYVGFNAT	TMPRSS15	316	P98073
EYSVDESAGYVEVQV	FREM2	2016	Q5SZK8
GQESDVAFAEGDIIY	FREM2	2881	Q5SZK8
DDDYVAVATSQGLVV	HPS5	86	Q9UPZ3
DVNNFVVGSEEGTVY	DYNC1I1	451	O14576
EYLSAFENSIGAVDE	C1D	16	Q13901
EADVIENEDGTYDIF	FLNB	1661	O75369
NEVGNSSDFYDIVVI	PCYOX1L	286	Q8NBM8
FASEEYRGSVVENSE	FAT2	2906	Q9NYQ8
VSAEDYFNVSLESGD	PCDHGB1	66	Q9Y5G3
AEDFDSGVNAELIYS	PCDH1	741	Q08174
EFLAAGDAVDVTQDY	PEX5	121	P50542
AGRISEEYFAQTDEE	PDE8B	796	O95263
GSIIAQDEIYEEASS	NEMP1	411	O14524
DEVEETGVVFSYNTD	NID1	371	P14543
NHFEDVYVGSETEFI	CRLF3	221	Q8IUI8
NGYASTDEEISEFSE	KIF21B	1101	O75037
DVDVVENHDGTFDIY	FLNC	1691	Q14315
VEAAEIVEGEDSAYS	FLNC	2261	Q14315
TEETHNYVGFEDIID	KIF20B	666	Q96Q89
VTVAQVNYSAVADGE	NRF1	341	Q16656
RLTTETFYEVNFDDG	KDM4A	921	O75164
YDVINAFENVDEVSA	KCNH1	306	O95259
VVETFFGYDEEASLE	JAKMIP3	451	Q5VZ66
FLDLNTEGYTSEEVA	LRRK2	2181	Q5S007
FSSVRYAQGVNEDEI	LY75	1701	O60449
LAESFFVDYEENEGA	ADAMTSL2	491	Q86TH1
SVNFSEAEGTEVTYE	LEPR	961	P48357
RIGVSYIFSNDDEDV	LRATD2	31	Q96KN1
ASIRVDTVEDFAYGA	LRAT	106	O95237
DTVEDFAYGANILVN	LRAT	111	O95237
EYDNVGEASEQTVSL	TUBGCP5	446	Q96RT8
EVASNITSFAVYDEF	ELP1	636	O95163
SGVAYTAEKEEDVGF	KCNS1	391	Q96KK3
QEGEVDFLSSVEAQY	FAM83A	56	Q86UY5
LVENGSYIVAVDFDS	LRP2	1461	P98164
NEDGTVRYFIDASQE	PRDM12	141	Q9H4Q4
GDAETAAAIEEEIYQ	MPND	321	Q8N594
YTTDENGEAQFSIDT	OVOS2	376	Q6IE36
AEDVDSGVNAEVSYS	PCDHB10	266	Q9UN67
YESVSVDPEDFVGQN	FOXRED2	201	Q8IWF2
FYEDGGDEDIVTISQ	NSFL1C	41	Q9UNZ2
YTFEVEAVNGVSDLS	EPHA7	411	Q15375
VSVESENYVQAVEEF	NASP	551	P49321
IYQVVGFDASTTVEE	PLEKHH2	1131	Q8IVE3
YDVVAQTADGVDADL	MVB12B	66	Q9H7P6
EYGEVTNVTTAVDIY	NRBP1	246	Q9UHY1
QEVEAEVAATGTYQL	NOS3	151	P29474
EGQGFVSEDEYLEIS	OPCML	176	Q14982
SDDEIVSLSIEFYEG	PCGF2	126	P35227
LFDVDVDDTTEEQGY	PORCN	416	Q9H237
SIVYSIVSGNEEDTF	PCDH15	1066	Q96QU1
SSGTVYEAAAVEVDV	FLT3	71	P36888
AAQYQFTDSETDVEG	DOCK9	1791	Q9BZ29
FVVGVADVDYNELAN	COL12A1	2456	Q99715
TSVIADLQEDEDGVY	PRMT3	206	O60678
DDIDAVIFATGYSFD	FMO5	321	P49326
AVSVAEDSVLYDGQV	BFSP1	496	Q12934
AAIDRAFEGVSYSQE	C3orf62	26	Q6ZUJ4
AATDINGDDYADVFI	ITGAV	311	P06756
FVSEIVDTVYEDGDS	COL6A3	1661	P12111
GSAIEYTIENVFESA	COL6A3	2716	P12111
TYAVVTVDDLDDGAN	FAT3	281	Q8TDW7
IVDYNTRFSGVTEAD	REXO1L1P	541	Q8IX06
AENAEDYEGRDVFNT	C1GALT1C1L	231	P0DN25
LITNDEAYAEEFGNE	CALR	331	P27797
AYDSVQIISGDTEEG	C1S	66	P09871
YNQEESVRFDSDVGE	HLA-DRB1	61	P01911
AAGEQDVFYEVSLDN	GOLGA6D	646	P0CG33
DVGENAEIEYSITDG	CDH6	296	P55285
GEYFTAIVQGDTLED	DLG2	831	Q15700
TGAVFSVDYNDELDI	FBXW2	226	Q9UKT8
LAYTEDEVVSTDFLG	GAPDHS	346	O14556
EDDSVQVQYVDGSTL	C5orf34	11	Q96MH7
SYAEDETDVEGTVNG	DNAJA3	426	Q96EY1
DVDDAIQFEVSIGNY	DYSF	606	O75923
DDSEISGYSVENAFF	IPO4	656	Q8TEX9
VFISAAERDVYTGDA	PSMB1	206	P20618
FVSGLESYIEDEDSF	FANCD2	96	Q9BXW9
RGEENTDYVNASFID	PTPRA	581	P18433
NTGEFQEVVRAFYDT	PARP10	826	Q53GL7
DVFSQDVFGQTAEDY	POTEA	256	Q6S8J7
QYSVLEETESGTFVA	PCDHB6	31	Q9Y5E3
VIENEETGEFSIDNY	MIA2	491	Q96PC5
GNVYFSDQHLVEEDT	MOXD2P	91	A6NHM9
TAVLDAFYDADVAVV	MAP3K15	111	Q6ZN16
YTVQFDVGVEFEEDL	RBP5	61	P82980
EAVAADVRTFSEGYI	TRIM45	271	Q9H8W5
FSFELDVEDGEVENY	RNF38	406	Q9H0F5
DIYQATESEVGDVDL	RAPGEF6	206	Q8TEU7
QATEDVDYTQVVFSD	RHEX	106	Q6ZWK4
YGVQLVEEGADTFTA	MRPL15	136	Q9P015
QVDSCVFAGEYEDTL	GTF3C6	56	Q969F1
EEEGYGESDVTFSVN	SYNM	786	O15061
TVGCVAGDEESYEVF	CKM	71	P06732
FERGAVDSYDVTVDE	ALOX5	46	P09917
NSQEETLEFVADYSG	PLCE1	731	Q9P212
VDYSIDEEAAFQAAL	RNF166	216	Q96A37
QSESGEDLYFSVELE	SNTG1	361	Q9NSN8
SFSSIGGYEVSEEEE	TAF1	1816	P21675
FKVTDDEEASQYVEG	GUCA1B	46	Q9UMX6
EDDEVYQVTVYQAGE	MDM2	271	Q00987
TSESTVVRDVFYDGN	SELENOO	221	Q9BVL4
AVGEFDGDLNTTEYV	ITGA2B	271	P08514
YLDVSEEGTEAAAAT	SERPINB11	336	Q96P15
VDVEALENSAGATYI	SRP72	516	O76094
YAFVSQGEVSVASID	MYH6	311	P13533
GFTQSQIDEIDHDYE	RIPK1	606	Q13546
AVENELQGSVTEYEF	NUP160	501	Q12769
LQGSVTEYEFSQEEF	NUP160	506	Q12769
STFRNYDVDFTVGVE	RBP2	56	P50120
DVAEAFLDVGEYNSA	GTF3C3	426	Q9Y5Q9
DGCIVFDVIAYEDNS	BCO1	316	Q9HAY6
AGSRTFVQEDIYDEF	ALDH2	321	P05091
EEDGTTVETEEYFQA	CIDEC	86	Q96AQ7
TVETEEYFQALAGDT	CIDEC	91	Q96AQ7
DADIIGYVASEEAFV	CLTB	166	P09497
DAVDGATESAELTYI	ATP11C	481	Q8NB49
DVDGNTYQVTFSEES	INPP5J	796	Q15735
EISQFVSEGYSVDEL	SWI5	176	Q1ZZU3
GDQSVVDASENYFVT	TMEM240	66	Q5SV17
GYQDSVTFDDVAVDF	ZNF561	36	Q8N587
GTTSYNEVADELVAE	TFDP1	131	Q14186
SYQDSVTFDDVAVEF	ZNF562	36	Q6V9R5
FEVEDAENVASYDSK	TPTE	66	P56180
EEDLNTIAEGDNVYA	USP43	341	Q70EL4
AVSDESVAGDSGVYE	WWC2	661	Q6AWC2
QGEAASADVEAAASY	TIGD1	151	Q96MW7
FAGYVTSIAATELED	SF3B1	51	O75533
VYVSIADYEGDEETA	SH3PXD2A	1076	Q5TCZ1
ESDEFTVDAARYGNV	SUV39H2	311	Q9H5I1
LTEEGQVSYDDVSVF	PPM1M	431	Q96MI6
GDDDYIEQTLVTVAA	YY1	141	P25490
EGYEQDFAVLTAEIT	VTI1A	6	Q96AJ9
YFTSVEIVDFSGENA	TTMP	146	Q5BVD1
EIVDFSGENATVTYD	TTMP	151	Q5BVD1
LAAVAVYFADVGTDV	XKR4	116	Q5GH76
LDTADFGYAVGEVEA	THTPA	146	Q9BU02
VEFGENQEFTDDIEY	WAPL	646	Q7Z5K2
FVEIEVAGAEYDSTK	PLCG1	1111	P19174
ENVSAFKTEYDAVAE	SMC4	861	Q9NTJ3
ENSLVLFEGDEVYST	SEMA7A	176	O75326
DEDSAVYSFEALVDG	VWA5A	56	O00534
VYFDETAQEIVDEFA	UNC13B	776	O14795
IFENVDYVQFGEDSS	TTC17	436	Q96AE7
RASGQESEEVADDYQ	RNF168	91	Q8IYW5
VYTNSVAAQDIVDDG	PLCH1	606	Q4KWH8
TADGYFETIVSALDE	ZNF862	666	O60290
DETYGVNVQFESDEE	SNRNP200	196	O75643
YDSVAFEDVAVNFTQ	ZNF442	26	Q9H7R0
GSDENEESSVVDYVE	ZHX2	781	Q9Y6X8
DAQAIEEFYGLTSDI	USP46	336	P62068
NTVIFYGADSEQADI	ZMYND11	226	Q15326
LESQAEISENYAGDV	ZNF16	86	P17020
VEAEDGQYDVLFIGT	SEMA3E	441	O15041
SKFEVEDAENVASYD	TPTE2	46	Q6XPS3
ETNVTENYELDVASG	TEX15	1401	Q9BXT5
VNYDNVVDTGSETDE	ZEB2	26	O60315
LDAFSEIDYVVSGEA	TRANK1	2501	O15050
RVYDQVGTQEFEDVS	THOP1	46	P52888
VGTQEFEDVSYESTL	THOP1	51	P52888
YKVSDVDEFGSVEAQ	TET2	1421	Q6N021
DYQVFTDAARFVTEG	PIGM	51	Q9H3S5
FESFVDYVAVEQLDG	USP7	361	Q93009
DVYFDNVGGNISDTV	PTGR2	226	Q8N8N7
YEDDVEELGLNFTVV	UBE3C	876	Q15386
YVVAELFTGSEDLDN	AGL	551	P35573
QTAFDVADEDILGYL	PPP1R12A	266	O14974